| Literature DB >> 12204772 |
Soo-Hyun Yoon1, Yun-Sook Kim, Sa-Youl Ghim, Bang-Ho Song, Young-Seuk Bae.
Abstract
Resveratrol is a phytoalexin found in grapes and other foods that has been shown to have anticancer and anti-inflammatory effects. Because protein kinase CKII is involved in cell proliferation and oncogenesis, we examined whether resveratrol could modulate CKII activity. Resveratrol was shown to inhibit the phosphotransferase activity of CKII with IC(50) of about 10 microM. Steady state studies revealed that resveratrol acted as a competitive inhibitor with respect to the substrate ATP. A value of 1.2 microM was obtained for the apparent K(i). Resveratrol also inhibited the catalytic reaction of CKII with GTP as substrate. Furthermore, resveratrol inhibits endogenous CKII activity on protein substrates in HeLa cell lysates. These results suggest that resveratrol is likely to function by inhibiting oncogenic disease, at least in part, through the inhibition of CKII activity.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12204772 DOI: 10.1016/s0024-3205(02)01997-5
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037